IGC Pharma, Inc. Quarterly Depreciation in USD from Q2 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
IGC Pharma, Inc. quarterly/annual Depreciation history and growth rate from Q2 2012 to Q3 2024.
  • IGC Pharma, Inc. Depreciation for the quarter ending September 30, 2024 was $145K, a 3.57% increase year-over-year.
  • IGC Pharma, Inc. Depreciation for the twelve months ending September 30, 2024 was $573K, a 48.4% increase year-over-year.
  • IGC Pharma, Inc. annual Depreciation for 2023 was $563K, a 35% increase from 2022.
  • IGC Pharma, Inc. annual Depreciation for 2022 was $417K, a 33.5% decline from 2021.
  • IGC Pharma, Inc. annual Depreciation for 2021 was $627K, a 35.7% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $573K $145K +$5K +3.57% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $568K $142K +$5K +3.65% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $563K $146K +$195K Jan 1, 2024 Mar 31, 2024 10-K 2024-06-24
Q4 2023 $368K $140K -$18K -11.4% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $386K $140K -$16K -10.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $402K $137K -$15K -9.87% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $417K -$49K -$250K -124% Jan 1, 2023 Mar 31, 2023 10-K 2024-06-24
Q4 2022 $667K $158K +$41K +35% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 $626K $156K -$1K -0.64% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $627K $152K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $627K $201K +$71K +54.6% Jan 1, 2022 Mar 31, 2022 10-K 2023-07-07
Q4 2021 $556K $117K -$7K -5.65% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 $563K $157K +$53K +51% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $510K $152K +$48K +46.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $462K $130K +$59K +83.1% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-23
Q4 2020 $403K $124K +$102K +464% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 $301K $104K +$80K +333% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-20
Q2 2020 $221K $104K +$87K +512% Apr 1, 2020 Jun 30, 2020 10-Q 2021-10-29
Q1 2020 $134K $71K Jan 1, 2020 Mar 31, 2020 10-K 2021-06-14
Q4 2019 $22K +$7K +46.7% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $24K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-20
Q2 2019 $17K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q4 2018 $15K Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q2 2014 $149K -$405 -0.27% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-14
Q2 2013 $149K +$65.7K +78.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q2 2012 $83.6K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.